10-KGTBPCIK 0000109657

GT Biopharma, Inc.

Name: SEC EDGAR filing 0001493152-26-008443
Creator: GT Biopharma, Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed March 2, 2026.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001493152-26-008443
Filer: GT Biopharma, Inc.
Ticker: GTBP
CIK: 0000109657
Form type: 10-K
Form description: Annual report
Filed at: March 2, 2026
Period of report: December 31, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 8.5 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from GT Biopharma, Inc.

See all 45 filings from GT Biopharma, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/109657/000149315226008443/0001493152-26-008443-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GT Biopharma, Inc. (0000109657) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.